| Date Initiated by Firm | May 31, 2005 |
| Date Posted | August 01, 2006 |
| Recall Status1 |
Terminated 3 on July 25, 2012 |
| Recall Number | Z-1315-06 |
| Recall Event ID |
35656 |
| Product Classification |
drug screen test - Product Code LCM
|
| Product | Medplus ER Drug Screen Test Model #5800KAB packaged as 25 individually pouched devices in a labeled kit box. |
| Code Information |
Lot Numbers Affected: 85699 and 85671 |
Recalling Firm/ Manufacturer |
Applied Biotech Inc 10237 Flanders Ct San Diego CA 92121-2901
|
| For Additional Information Contact | Carmen Bergelin 858-713-9640 |
Manufacturer Reason for Recall | The firm has discovered that a number of distributed devices of the Medplus ER Drug Screen Test may be incorrectly assembled which may give incorrect results. The product is an in vitro test for rapid detection of various drugs such as Amphetamines, Barbiturates, Phencyclidine, Cocaine, Methamphetamine, Tricyclic Antidepressants, Morphine, Tetrahydrocannabinol, & Benzodiazepines in human urine. |
FDA Determined Cause 2 | Other |
| Action | Recall notifications that describe the problem, dated May 31,2005, were sent via fax. Customers were instructed to block all stock of affected lots in their warehouse, contact their primary consignees and advise them to discontinue use immediately and dispose any unused materials. A faxback form was used to communicate to the recalling firm the quantity blocked and disposed of. Arrangements were made for providing replacement product. |
| Quantity in Commerce | Lot #85699: 71 kits (1775 devices) & Lot #85671: 44 kits (1100 devices) |
| Distribution | Nationwide (distributors in KS and OR). |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|